ioflupane: Clinical Trials

2 trials of ioflupane, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow ioflupane: new trials by email Literature Review of ioflupane trials Research Report on ioflupane

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.
DaTSCAN™ Ioflupane (123I) Injection - Healthy Subjects (HS)
Phase 1CompletedGE Healthcare92021-05-132023-08-02
Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls
(11C)PE2I, Ioflupane - Parkinson Disease, REM Sleep Behavior Disorder
Phase 1 / Phase 2CompletedWeill Medical College of Cornell University822018-08-142025-03-12

Conditions studied

Parkinson Disease (1)  ·  REM Sleep Behavior Disorder (1)

Sponsors

GE Healthcare (1)  ·  Weill Medical College of Cornell University (1)

Countries

China (1)  ·  United States (1)

Top investigators

Alexander Shtilbans, MD (1)  ·  Biao LI (1)

Results publications

PMID 37029298

NIH funding

R01NS095562 (1)